Metraipolis › archive › dc_523c07ed249b

Safety, Tolerability, and Pharmacokinetics of the Long-Acting SARS-CoV-2-Neutralizing Monoclonal Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) in… — Europe PMC PMID:40799036

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40799036
DOI
10.1002/cpdd.1583
License (as archived)
solo-consultazione
Archived
2026-11-10T16:19:16.667Z
SHA-256 of the archived text
d9cd1d70264cddaa96e1550c64ce7d366065af87c13eb04fcd6b276186430c80
Stable URL of this page
https://metraipolis.com/documento/dc_523c07ed249b

How to cite

Safety, Tolerability, and Pharmacokinetics of the Long-Acting SARS-CoV-2-Neutralizing Monoclonal Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) in… — Europe PMC PMID:40799036 — Europe PMC (en), https://europepmc.org/article/MED/40799036 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_523c07ed249b (Metraipolis archive dc_523c07ed249b, sha256 d9cd1d70264cddaa96e1550c64ce7d366065af87c13eb04fcd6b276186430c80)
BibTeX
@misc{dc523c07ed249b,
  title = {Safety, Tolerability, and Pharmacokinetics of the Long-Acting SARS-CoV-2-Neutralizing Monoclonal Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) in… — Europe PMC PMID:40799036},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40799036},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_523c07ed249b; sha256 d9cd1d70264cddaa96e1550c64ce7d366065af87c13eb04fcd6b276186430c80},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40799036. Agents can read the archived copy with the MCP tool read_document.